Download presentation
Presentation is loading. Please wait.
Published byBambang Sanjaya Modified over 5 years ago
1
Clinical outcomes with daptomycin: a post-marketing, real-world evaluation
G. Sakoulas Clinical Microbiology and Infection Volume 15, Pages (December 2009) DOI: /j x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions
2
FIG. 1 Infection types of the 2332 patients (includes non-evaluable patients) treated with daptomycin in 2004 and 2005 [25]. cSSTI, complicated skin and soft tissue infection; IE, infective endocarditis; uSSTI, uncomplicated skin and soft tissue infection. *Other: foreign-body infections, septic arthritis, urinary tract infections, central nervous system infections, and necrotizing infections. Clinical Microbiology and Infection , 11-16DOI: ( /j x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.